Investors Should Take Note Of Allogene Therapeutics Inc (ALLO)
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
Are Analysts Expecting A Better 2020 For Allogene Therapeutics Inc (ALLO)?
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
Allogene Therapeutics Inc (ALLO) Outlook Starting To Look Brighter?
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
